Quick Answer
Annovis Bio, Inc. reported Net Income Loss of -$28.85 million for the year ending 2025.
- Annovis Bio, Inc. showed a decrease of -17.3% in Net Income Loss from 2024 to 2025.
- This data is from Annovis Bio, Inc.'s annual report (Form 10-K), filed with the SEC on March 13, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 7 years of available data (2019 to 2025), Annovis Bio, Inc.'s Net Income Loss has declined by 2,811.7%.
- Historical annual values: Fiscal year 2025: -$28.85 million | Fiscal year 2024: -$24.59 million | Fiscal year 2023: -$56.20 million | Fiscal year 2022: -$25.33 million | Fiscal year 2021: -$14.49 million | Fiscal year 2020: -$5.46 million | Fiscal year 2019: -$991.0 thousand.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: